Navigation Links
St. Jude Discovers Factors That Accelerate Resistance to Gleevec(TM) Targeted Therapy in Lymphoblastic Leukemia
Date:8/29/2007

s in the BCR-ABL protein, which prompt imatinib resistance.

A report on these results appears in the September 15 issue of "Genes & Development."

"The findings also imply that doctors might identify patients at high risk of failing this treatment by determining whether their leukemia cells lack the Arf gene," said Richard T. Williams, M.D., Ph.D., an assistant member in the St. Jude Department of Oncology and the paper's first author.

This study strongly suggests that a widely held explanation for how leukemias arise is not universally applicable. "This view holds that leukemias arise from rare 'cancer stem cells,' which do not make up the bulk of the tumor, but are the only cells required to regenerate the cancer after treatment," Williams said. "However the new St. Jude study reveals that the combination of BCR-ABL activity and inactivation of Arf are sufficient to generate a uniform population of leukemia-initiating cells -- any one of which can expand and induce rapidly fatal disease."

The other author of the paper was Willem den Besten (St. Jude).

This was supported by funding from Howard Hughes Medical Institute, a Cancer Center Core Grant and ALSAC.

St. Jude Children's Research Hospital

St. Jude Children's Research Hospital is internationally recognized for its pioneering work in finding cures and saving children with cancer and other catastrophic diseases. Founded by late entertainer Danny Thomas and based in Memphis, Tenn., St. Jude freely shares its discoveries with scientific and medical communities around the world. No family ever pays for treatments not covered by insurance, and families without insurance are never asked to pay. St. Jude is financially supported by ALSAC, its fundraising organization. For more information, please visit http://www.stjude.org.


'/>"/>
SOURCE St. Jude Children's Research Hospital
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Millennium Discovers Biomarkers Potentially Predictive of Response to Velcade (Bortezomib) for Injection
2. Research Supported by Samuel Waxman Cancer Research Foundation Discovers Mode of Action of Arsenic-Based Drugs in Destroying Cancer Cells
3. Byetta Treatment for Three and a Half Years Associated with Reductions in Cardiovascular Risk Factors in People with Type 2 Diabetes
4. Treating Heart Disease Risk Factors May Slow Alzheimers Disease Progression
5. Researchers Identify New Genetic Risk Factors for Type 2 Diabetes
6. Inflazyme Announces Outcome of Review of Phase 2b Asthma Study: Potential Mitigating Factors Identified which Prevent Clear Interpretation of Results
7. Antibiotics Dont Prevent Future Urinary Tract Infections, May Cause Resistance in Future Infections
8. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
9. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
10. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
11. Pharmasset Presents Clevudine and Racivir Data at the International HIV Drug Resistance Workshop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... --  Sigma-Aldrich Corporation (NASDAQ: SIAL ) a leading ... $50,000 product donation to the Reproducibility Project: Cancer ... from recent high-impact papers in the field of cancer ... research marketplace Science Exchange , the non-profit ... eLife. The goal of the project is ...
(Date:5/6/2015)... 2015 First programme ... and rilpivirine   ViiV Healthcare ... clinical trial programme to evaluate the safety and ... ) as maintenance therapy for adult patients with ... studies evaluating 48 week viral suppression with a ...
(Date:5/5/2015)... BARCELONA, Spain , May 6, 2015 ... and aspires to lead the European market in the ... Through this alliance ECUPHAR acquires all the assets ... the new organization in the coming weeks. Being both ... not been disclosed.      (Photo: http://photos.prnewswire.com/prnh/20150506/743274 ...
Breaking Medicine Technology:Sigma-Aldrich Donates $50K in Products to the Reproducibility Project to Foster Replicable Research and Accelerate Scientific Discoveries in Cancer Biology 2Sigma-Aldrich Donates $50K in Products to the Reproducibility Project to Foster Replicable Research and Accelerate Scientific Discoveries in Cancer Biology 3ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 2ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 3ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 4ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 5ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 6ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 7ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 8ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 9ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 10ECUPHAR Enters the Spanish and Southern European Markets Through ESTEVE 2
... of its ongoing,efforts to develop research tools that ... disease, The Michael J. Fox,Foundation announced the launch ... the Foundation seeks to drive the creation,and testing ... with a personal,computer and an Internet connection to ...
... March 19 FluoroPharma Inc., a company,developing breakthrough ... (PET) market, announced commencement of Phase,I clinical trials ... the proposed studies. The Phase I trial is ... safety, distribution and dosimetry,of BFPET as a PET ...
Cached Medicine Technology:New Michael J. Fox Foundation Initiative Will Drive Development of Web-Based Tools to Increase Patient Participation in Parkinson's Clinical Trials 2FluoroPharma Announces Commencement of Phase I Clinical Trial for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2
(Date:5/6/2015)... (PRWEB) May 06, 2015 The GUARDaHEART ... Starbucks Community Resource Exchange with the mission of providing ... County families in need on Thursday, April 30th. ... an advanced blood test for the early-detection and diagnosis ... life changing advanced medical testing to homeless individuals and ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 On ... Choices Recovery sponsored Durkin Entertainment’s “RockNRolla” EcoLuxe Lounge, ... providers of products and services that maintain ecologically ... Durkin, Los Angeles’ leading producer of TV and ... is a premier red carpet event that makes ...
(Date:5/6/2015)... 06, 2015 Aging2.0 - ... announced the latest lineup of speakers and sponsors for ... invitation-only event, scheduled for May 18-19 in San Francisco, ... consumer technology leaders, investors and more than 50 startups ... partnerships and discover new products and services for the ...
(Date:5/6/2015)... National Physical Fitness and Sports Month , The ... Department of Health and Human Services (HHS), designates the ... Month. It is dedicated to raising public awareness ... Throughout the month of May, Americans are challenged to ... HHS details the benefits of regular daily and weekly ...
(Date:5/6/2015)... Established by the Arthritis Foundation, the ... 46 million Americans who suffer from arthritis. Many who ... alleviate their symptoms. Medicationdiscountcard.com is proud to offer a ... on the costs of these necessary prescriptions. , Non-Steroidal ... the pain and inflammation in the joints associated with ...
Breaking Medicine News(10 mins):Health News:GUARDaHEART and Starbucks® Collaborate for Impactful Event to Help Homeless Families 2Health News:Choices Recovery Mishawaka Discusses the Many Forms of Addiction and Treatment with Terrah Bennett Smith 2Health News:Aging2.0 Global Innovation Summit Provides Unique Forum to Discover New Technologies and Develop Partnerships in the Senior Care Market 2Health News:Aging2.0 Global Innovation Summit Provides Unique Forum to Discover New Technologies and Develop Partnerships in the Senior Care Market 3Health News:Aging2.0 Global Innovation Summit Provides Unique Forum to Discover New Technologies and Develop Partnerships in the Senior Care Market 4Health News:Narconon Arrowhead Issues Guide for Physical Fitness and Sports Month 2Health News:Narconon Arrowhead Issues Guide for Physical Fitness and Sports Month 3Health News:Medicationdiscountcard.com Provides Access to Drug Coupons for Arthritis Awareness Month 2Health News:Medicationdiscountcard.com Provides Access to Drug Coupons for Arthritis Awareness Month 3
... TV coverage of terrorism has more negative effect on women. ... University of Haifa. "It is possible that the differences between ... to respond to terrorism with more anxiety than men," said ... Exposure to television coverage of terrorism causes women ...
... By Serena Gordon HealthDay Reporter , ... treatment performed significantly better than the commonly prescribed medication ... briakinumab reduced psoriasis symptoms by at least 75 percent ... to just 40 percent of those on methotrexate. But ...
... THURSDAY, Oct. 27 (HealthDay News) -- Older people who ... greater risk for complications and disability following surgery, according ... of Colorado said surgeons should assess the elderly differently ... when determining surgical risks. "This approach may lead ...
... Endocrine Society,s Journal of Clinical Endocrinology & Metabolism ... associated with reduced loss of lean muscle mass in older ... these men, higher testosterone levels were also associated with less ... and strength contribute to frailty and are associated with falls, ...
... D.C. -- A new study suggests some women needing a ... potential option that is safe and effective, say researchers at ... sparing mastectomy is also a viable surgical option for women ... increased risk of developing the disease. For both groups ...
... was found to be ineffective in reducing atherosclerosis ... erythematosus (SLE). Results of the Atherosclerosis Prevention in ... Arthritis & Rheumatism , a journal published ... of Rheumatology (ACR), report that the statin therapy ...
Cached Medicine News:Health News:Gender differences: Viewing TV coverage of terrorism has more negative effect on women 2Health News:Experimental Psoriasis Drug Bests Older Treatment 2Health News:Experimental Psoriasis Drug Bests Older Treatment 3Health News: Slower Walking Speed Linked to Surgical Risk in Elderly 2Health News: Slower Walking Speed Linked to Surgical Risk in Elderly 3Health News:Older men with higher testosterone levels lose less muscle mass as they age 2Health News:Georgetown researchers examine 21-year series of nipple sparing mastectomy cases and find no cancers 2Health News:Statin therapy fails to slow progression of atherosclerosis in pediatric lupus patients 2
All-natural porcine collagen can be used in open or laparoscopic placement....
... SBI RingFix is a modular external fixation ... large variety of clinical needs. Originally marketed ... has a successful 20 year history of ... Developed around the principles of the Ilizarov ...
... The six models of Thermo Scientific ... mL to 60 mL with very high ... careful design of all components. The Finnpipette ... the extensive Thermo Scientific Finnpipette manual liquid ...
... collection benefits from innovative research in materials ... such as the aerospace and automotive industry, ... and the footwear and textile industry. , ... in the Carrera sunglasses collection to create ...
Medicine Products: